Gupta, S. C., Kim, J. H., Prasad, S., & Aggarwal, B. B. (2010). Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Reviews, 29, 405–434. https://doi.org/10.1007/s10555-010-9235-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Spiros, A. V. (2017). Aberrant control of NF-ΚB in cancer permits transcriptional and phenotypic plasticity, to curtail dependence on host tissue: molecular mode. Cancer Biology & Medicine, 14, 254. https://doi.org/10.20892/j.issn.2095-3941.2017.0029

Article  CAS  Google Scholar 

Espinoza-Sánchez, N. A., Enciso, J., Pelayo, R., & Fuentes-Pananá, E. M. (2018). An NFκB-dependent mechanism of tumor cell plasticity and lateral transmission of aggressive features. Oncotarget, 9, 26679–26700. https://doi.org/10.18632/oncotarget.25465

Article  PubMed  PubMed Central  Google Scholar 

Shi, Z.-D., Pang, K., Wu, Z.-X., Dong, Y., Hao, L., Qin, J.-X., Wang, W., Chen, Z.-S., & Han, C.-H. (2023). Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies. Signal Transduction and Targeted Therapy, 8, 1–21. https://doi.org/10.1038/s41392-023-01383-x

Article  Google Scholar 

Xia, L., Tan, S., Zhou, Y., Lin, J., Wang, H., Oyang, L., Tian, Y., Liu, L., Su, M., Wang, H., et al. (2018). Role of the NFκB-signaling pathway in cancer. OncoTargets and Therapy, 11, 2063–2073. https://doi.org/10.2147/OTT.S161109

Article  PubMed  PubMed Central  Google Scholar 

Saha, S., Pradhan, N., Neha, B., Mahadevappa, R., Minocha, S., & Kumar, S. (2023). Cancer plasticity: investigating the causes for this agility. Seminars in Cancer Biology, 88, 138–156. https://doi.org/10.1016/j.semcancer.2022.12.005

Article  CAS  PubMed  Google Scholar 

Rinkenbaugh, A. L., & Baldwin, A. S. (2016). The NF-ΚB pathway and cancer stem cells. Cells, 5, 16. https://doi.org/10.3390/cells5020016

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang, X., Zhang, H., & Chen, X. (2019). Drug resistance and combating drug resistance in cancer. Cancer Drug Resistance. https://doi.org/10.20517/cdr.2019.10

Devanaboyina, M., Kaur, J., Whiteley, E., Lin, L., Einloth, K., Morand, S., Stanbery, L., Hamouda, D., & Nemunaitis, J. (2022). NF-ΚB signaling in tumor pathways focusing on breast and ovarian cancer. Oncology Reviews, 16, 10568. https://doi.org/10.3389/or.2022.10568

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ashrafizadeh, M., Zarrabi, A., Hushmandi, K., Kalantari, M., Mohammadinejad, R., Javaheri, T., & Sethi, G. (2020). Association of the epithelial–mesenchymal transition (EMT) with cisplatin resistance. International Journal of Molecular Sciences, 21, 4002. https://doi.org/10.3390/ijms21114002

Article  CAS  PubMed  Google Scholar 

Mirzaei, S., Saghari, S., Bassiri, F., Raesi, R., Zarrabi, A., Hushmandi, K., Sethi, G., & Tergaonkar, V. (2022). NF-κB as a regulator of cancer metastasis and therapy response: a focus on epithelial–mesenchymal transition. Journal of Cellular Physiology, 237, 2770–2795. https://doi.org/10.1002/jcp.30759

Article  CAS  PubMed  Google Scholar 

Bharti, A. C., & Aggarwal, B. B. (2002). Chemopreventive agents induce suppression of nuclear factor-kappaB leading to chemosensitization. Annals of the New York Academy of Sciences, 973, 392–395. https://doi.org/10.1111/j.1749-6632.2002.tb04671.x

Article  CAS  PubMed  Google Scholar 

Prasad, S., Phromnoi, K., Yadav, V. R., Chaturvedi, M. M., & Aggarwal, B. B. (2010). Targeting inflammatory pathways by flavonoids for prevention and treatment of cancer. Planta Medica, 76, 1044–1063. https://doi.org/10.1055/s-0030-1250111

Article  CAS  PubMed  Google Scholar 

Yadav, V. R., Prasad, S., Sung, B., Kannappan, R., & Aggarwal, B. B. (2010). Targeting inflammatory pathways by triterpenoids for prevention and treatment of cancer. Toxins, 2, 2428–2466. https://doi.org/10.3390/toxins2102428

Article  CAS  PubMed  Google Scholar 

Godwin, P., Baird, A. M., Heavey, S., Barr, M. P., O’Byrne, K. J., & Gately, K. (2013). Targeting nuclear factor-kappa B to overcome resistance to chemotherapy. Frontiers in Oncology, 3. https://doi.org/10.3389/fonc.2013.00120

Liu, D.-L., Li, Y.-J., Yang, D.-H., Wang, C.-R., Xu, J., Yao, N., Zhang, X.-Q., Chen, Z.-S., Ye, W.-C., & Zhang, D.-M. (2015). Ganoderma lucidum derived ganoderenic acid B reverses ABCB1-mediated multidrug resistance in HepG2/ADM cells. International Journal of Oncology, 46, 2029–2038. https://doi.org/10.3892/ijo.2015.2925

Article  CAS  PubMed  Google Scholar 

Robey, R. W., Pluchino, K. M., Hall, M. D., Fojo, A. T., Bates, S. E., & Gottesman, M. M. (2018). Revisiting the role of ABC transporters in multidrug-resistant cancer. Nature Reviews. Cancer, 18, 452–464. https://doi.org/10.1038/s41568-018-0005-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liskova, A., Samec, M., Koklesova, L., Brockmueller, A., Zhai, K., Abdellatif, B., Siddiqui, M., Biringer, K., Kudela, E., Pec, M., et al. (2021). Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles. The EPMA Journal, 1–22. https://doi.org/10.1007/s13167-021-00242-5

Meerson, A., Khatib, S., & Mahajna, J. (2021). Flavonoids targeting cancer stem cells for augmenting cancer therapeutics. International Journal of Molecular Sciences, 22, 13044. https://doi.org/10.3390/ijms222313044

Article  CAS  PubMed Central  Google Scholar 

Telang, N. T. (2023). Natural products as drug candidates for breast cancer (review). Oncology Letters, 26, 349. https://doi.org/10.3892/ol.2023.13935

Article  PubMed  PubMed Central  Google Scholar 

Mazurakova, A., Koklesova, L., Vybohova, D., Samec, M., Kudela, E., Biringer, K., Šudomová, M., Hassan, S. T. S., Kello, M., Büsselberg, D., et al. (2023). Therapy-resistant breast cancer in focus: clinically relevant mitigation by flavonoids targeting cancer stem cells. Frontiers in Pharmacology, 14, 1160068. https://doi.org/10.3389/fphar.2023.1160068

Article  CAS  PubMed  PubMed Central  Google Scholar 

Samec, M., Mazurakova, A., Lucansky, V., Koklesova, L., Pecova, R., Pec, M., Golubnitschaja, O., Al-Ishaq, R. K., Caprnda, M., Gaspar, L., et al. (2023). Flavonoids attenuate cancer metabolism by modulating lipid metabolism, amino acids, ketone bodies and redox state mediated by Nrf2. European Journal of Pharmacology, 949, 175655. https://doi.org/10.1016/j.ejphar.2023.175655

Article  CAS  PubMed  Google Scholar 

Mazurakova, A., Koklesova, L., Csizmár, S. H., Samec, M., Brockmueller, A., Šudomová, M., Biringer, K., Kudela, E., Pec, M., Samuel, S. M., et al. (2023). Significance of flavonoids targeting PI3K/Akt/HIF-1α signaling pathway in therapy-resistant cancer cells – a potential contribution to the predictive, preventive, and personalized medicine. Journal of Advanced Research. https://doi.org/10.1016/j.jare.2023.02.015

Kubatka, P., Mazurakova, A., Samec, M., Koklesova, L., Zhai, K., AL-Ishaq, R., Kajo, K., Biringer, K., Vybohova, D., Brockmueller, A., et al. (2021). Flavonoids against non-physiologic inflammation attributed to cancer initiation, development, and progression—3PM pathways. The EPMA Journal, 12, 559–587. https://doi.org/10.1007/s13167-021-00257-y

Article  PubMed  PubMed Central  Google Scholar 

Zhai, K., Mazurakova, A., Koklesova, L., Kubatka, P., & Büsselberg, D. (1841). Flavonoids synergistically enhance the anti-glioblastoma effects of chemotherapeutic drugs. Biomolecules, 2021, 11. https://doi.org/10.3390/biom11121841

Article  CAS  Google Scholar 

Koklesova, L., Liskova, A., Samec, M., Zhai, K., Al-Ishaq, R. K., Bugos, O., Šudomová, M., Biringer, K., Pec, M., Adamkov, M., et al. (2021). Protective effects of flavonoids against mitochondriopathies and associated pathologies: focus on the predictive approach and personalized prevention. International Journal of Molecular Sciences, 22, 8649. https://doi.org/10.3390/ijms22168649

Article  CAS  PubMed  PubMed Central  Google Scholar 

AL-Ishaq, R. K., Liskova, A., Kubatka, P., & Büsselberg, D. (2021). Enzymatic metabolism of flavonoids by gut microbiota and its impact on gastrointestinal cancer. Cancers, 13. https://doi.org/10.3390/cancers13163934

Samec, M., Liskova, A., Koklesova, L., Mersakova, S., Strnadel, J., Kajo, K., et al. (2021). Flavonoids targeting HIF-1: implications on cancer metabolism. Cancers, 13, 130. https://doi.org/10.3390/cancers13010130

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liskova, A., Koklesova, L., Samec, M., Varghese, E., Abotaleb, M., Samuel, S. M., et al. (2020). Implications of flavonoids as potential modulators of cancer neovascularity. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-020-03383-8

Samec, M., Liskova, A., Koklesova, L., Samuel, S. M., Zhai, K., Buhrmann, C., Varghese, E., Abotaleb, M., Qaradakhi, T., Zulli, A., et al. (2020). Flavonoids against the Warburg phenotype-concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism. The EPMA Journal, 11, 377–398. https://doi.org/10.1007/s13167-020-00217-y

Article  PubMed  PubMed Central  Google Scholar 

Liskova, A., Koklesova, L., Samec, M., Smejkal, K., Samuel, S. M., Varghese, E., Abotaleb, M., Biringer, K., Kudela, E., Danko, J., et al. (2020). Flavonoids in cancer metastasis. Cancers, 12, 1498. https://doi.org/10.3390/cancers12061498

Article  CAS  PubMed  PubMed Central  Google Scholar 

Varghese, E., Liskova, A., Kubatka, P., Samuel, S. M., & Büsselberg, D. (2020). Anti-angiogenic effects of phytochemicals on MiRNA regulating breast cancer progression. Biomolecules, 10. https://doi.org/10.3390/biom10020191

Abotaleb, M., Samuel, S., Varghese, E., Varghese, S., Kubatka, P., Liskova, A., & Büsselberg, D. (2018). Flavonoids in cancer and apoptosis. Cancers, 11, 28. https://doi.org/10.3390/cancers11010028

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kubatka, P., Kello, M., Kajo, K., Kruzliak, P., Výbohová, D., Šmejkal, K., Maršík, P., Zulli, A., Gönciová, G., Mojžiš, J., et al. (2016). Young barley indicates antitumor effects in experimental breast cancer in vivo and in vitro. Nutrition and Cancer, 68, 611–621. https://doi.org/10.1080/01635581.2016.1154577

Article  CAS  PubMed  Google Scholar 

Kubatka, P., Kapinová, A., Kello, M., Kruzliak, P., Kajo, K., Výbohová, D., et al. (2016). Fruit peel polyphenols demonstrate substantial anti-tumour effects in the model of breast cancer. European Journal of Nutrition, 55, 955–965. https://doi.org/10.1007/s00394-015-0910-5

Article  CAS  PubMed  Google Scholar 

Tsai, S. H., Liang, Y. C., Lin-Shiau, S. Y., & Lin, J. K. (1999). Suppression of TNFalpha-mediated NFkappaB activity by myricetin and other flavonoids through downregulating the activity of IKK in ECV304 cells. Journal of Cellular Biochemistry, 74, 606–615.